RiskMastery's Breakout Stocks - CYP EditionWelcome to RiskMastery's Breakout Stocks - Stocks with breakout potential.
In this edition, we'll be looking at ASX:CYP ...
I believe this code is at a point of potential volatility.
If price can hold above $0.200 ... Bullish potential may be unlocked.
My key upside targets include:
-
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.055 AUD
−9.74 M AUD
0.00 AUD
155.47 M
About CYNATA THERAPEUTICS LIMITED
Sector
Industry
CEO
Kilian Kelly
Website
Headquarters
Cremorne
Founded
2003
ISIN
AU000000CYP7
FIGI
BBG000TKBTN2
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on proprietary mesenchymal stem cell technology. The company was founded on March 12, 2003 and is headquartered in Carlton, Australia.
Broken trend now looking for run higherDowntrend was broken at the start of the month with good volume but yet to really offer big breakout. Looking for a fill up to 0.775 (resistance from early jan). Once past that, not much stopping it up to 0.870 or higher.
Stop at 0.655 which looks like a base
RSI has plenty of room run
CYP - Technical Bullish Flag + CV TailwindsClassic bullish flag forming in the Cynata Therapeutics chart. Not the best time for the technicals to line up as far as the overall market in concerned, but this looks to be High probabilty trade on the back of their cv19 tailwinds/fundamentals as they turn their attention to virus treatments (cv19
$CYP - CYNATA - Up or Down ?Cynata has been having a good run of late, but is back up against its previous all time high. If it can push through I would take a punt on it to continue. It hit $1.65 in todays early trade but back down to $1.52 now. One to watch for now.
Cynata Therapeutics Limited is a stem cell and regenerativ
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CYP is 0.215 AUD — it has decreased by −3.64% in the past 24 hours. Watch CYNATA THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CYNATA THERAPEUTICS LIMITED stocks are traded under the ticker CYP.
CYP stock has fallen by −5.78% compared to the previous week, the month change is a −15.20% fall, over the last year CYNATA THERAPEUTICS LIMITED has showed a 72.00% increase.
We've gathered analysts' opinions on CYNATA THERAPEUTICS LIMITED future price: according to them, CYP price has a max estimate of 0.75 AUD and a min estimate of 0.75 AUD. Watch CYP chart and read a more detailed CYNATA THERAPEUTICS LIMITED stock forecast: see what analysts think of CYNATA THERAPEUTICS LIMITED and suggest that you do with its stocks.
CYP stock is 3.72% volatile and has beta coefficient of −1.15. Track CYNATA THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is CYNATA THERAPEUTICS LIMITED there?
Today CYNATA THERAPEUTICS LIMITED has the market capitalization of 38.42 M, it has decreased by −9.57% over the last week.
Yes, you can track CYNATA THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
CYNATA THERAPEUTICS LIMITED is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
CYP net income for the last half-year is −5.20 M AUD, while the previous report showed −4.54 M AUD of net income which accounts for −14.59% change. Track more CYNATA THERAPEUTICS LIMITED financial stats to get the full picture.
No, CYP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYNATA THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CYNATA THERAPEUTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CYNATA THERAPEUTICS LIMITED stock shows the sell signal. See more of CYNATA THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.